Who
Theodore R. Samuels II
Director
Company insider
Files Form 4 as: Director, Iron Mountain Incorporated (Delaware); Director, Bristol-Myers Squibb; Director, Centene; Director, Perrigo Company; Director, Stamps.Com.
In numbers
- Trades disclosed
- 172
- Buys
- 13
- Sells
- 0
- Bought
- $4.2M
- Sold
- $0
- Companies
- 5
- Companies where not an officer
- 5
- First trade
- 4 Jan 2017
- Last trade
- 6 Oct 2026
- Last filed
- 8 Oct 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 6 Oct 2026filed 8 Oct 2026 | IRM Iron Mountain Incorporated (Delaware)option or derivative · REITs | SEC FORM 4 Code A | $36K310.49 at $116.75 | filing |
| 2 Oct 2026filed 5 Oct 2026 | IRM Iron Mountain Incorporated (Delaware)option or derivative · REITs | SEC FORM 4 Code A | $12K104.67 at $113.92 | filing |
| 30 Sep 2026filed 2 Oct 2026 | BMY Bristol-Myers Squibboption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $51K821.314 at $62.40 | filing |
| 30 Sep 2026filed 30 Sep 2026 | CNC CenteneManaged Care & Insurers | SEC FORM 4 Code A | —583 at $0.00 | filing |
| 30 Sep 2026filed 30 Sep 2026 | CNC CenteneManaged Care & Insurers | SEC FORM 4 Code A | —583 at $0.00 | filing |
| 6 Jul 2026filed 7 Jul 2026 | IRM Iron Mountain Incorporated (Delaware)option or derivative · REITs | SEC FORM 4 Code A | $12K99.06 at $116.79 | filing |
| 6 Jul 2026filed 7 Jul 2026 | IRM Iron Mountain Incorporated (Delaware)option or derivative · REITs | SEC FORM 4 Code A | $12K99.06 at $116.79 | filing |
| 2 Jul 2026filed 6 Jul 2026 | IRM Iron Mountain Incorporated (Delaware)option or derivative · REITs | SEC FORM 4 Code A | $36K310.86 at $116.61 | filing |
| 2 Jul 2026filed 6 Jul 2026 | IRM Iron Mountain Incorporated (Delaware)option or derivative · REITs | SEC FORM 4 Code A | $36K310.86 at $116.61 | filing |
| 30 Jun 2026filed 2 Jul 2026 | BMY Bristol-Myers Squibboption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $51K889.448 at $57.62 | filing |
| 30 Jun 2026filed 2 Jul 2026 | BMY Bristol-Myers Squibboption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $51K889.45 at $57.62 | filing |
| 30 Jun 2026filed 1 Jul 2026 | CNC CenteneManaged Care & Insurers | SEC FORM 4 Code A | —465 at $0.00 | filing |
| 30 Jun 2026filed 1 Jul 2026 | CNC CenteneManaged Care & Insurers | SEC FORM 4 Code A | —465 at $0.00 | filing |
| 12 May 2026filed 13 May 2026 | CNC CenteneManaged Care & Insurers | SEC FORM 4 Code A | —3,992 at $0.00 | filing |
| 12 May 2026filed 13 May 2026 | CNC CenteneManaged Care & Insurers | SEC FORM 4 Code A | —3,992 at $0.00 | filing |
| 7 May 2026filed 11 May 2026 | IRM Iron Mountain Incorporated (Delaware)option or derivative · REITs | SEC FORM 4 Code A | —1,892 at $0.00 | filing |
| 7 May 2026filed 11 May 2026 | IRM Iron Mountain Incorporated (Delaware)option or derivative · REITs | SEC FORM 4 Code A | —1,892 at $0.00 | filing |
| 6 Apr 2026filed 7 Apr 2026 | IRM Iron Mountain Incorporated (Delaware)option or derivative · REITs | SEC FORM 4 Code A | $36K349.88 at $103.61 | filing |
| 6 Apr 2026filed 7 Apr 2026 | IRM Iron Mountain Incorporated (Delaware)option or derivative · REITs | SEC FORM 4 Code A | $9,55292.27 at $103.52 | filing |
| 6 Apr 2026filed 7 Apr 2026 | IRM Iron Mountain Incorporated (Delaware)option or derivative · REITs | SEC FORM 4 Code A | $36K349.88 at $103.61 | filing |
News
Bristol Myers Squibb Moves On Two Fronts: MS Cell Therapy Data And Tempus AI Expansion; Stock DownBMY · rttnews.com · 23 Oct 2026Bristol Myers Squibb Reports CAR T-Cell Therapy Data In Multiple SclerosisBMY · rttnews.com · 23 Oct 2026Better Dividend Stock to Buy and Hold: Pfizer or Bristol Myers Squibb?BMY · aol.com · 23 Oct 2026116,170 Shares in Perrigo Company plc $PRGO Bought by TD Waterhouse Canada Inc.PRGO · dailypolitical.com · 22 Oct 2026Ovid Therapeutics (NASDAQ:OVID) and Perrigo (NYSE:PRGO) Head to Head ReviewPRGO · themarketsdaily.com · 20 Oct 2026Centene exiting Hawaii's Med-QUEST program at end of year | Honolulu Star-AdvertiserCNC · staradvertiser.com · 18 Oct 2026Centene (NYSE:CNC) vs. Exagen (NASDAQ:XGN) Head to Head SurveyCNC · themarketsdaily.com · 14 Oct 2026Accel Wealth Management Buys New Holdings in Centene Corporation $CNCCNC · dailypolitical.com · 14 Oct 2026
0 headlines in the last 90 days name Theodore R. Samuels II; 9 articles from the last 14 days about the 3 companies they traded most, at most three about any one of them.